Introducing the HARMONY Data Exploration Tools – dashboards designed to empower experts to conduct statistical analyses on anonymous data related to hematologic malignancies. These are public versions specially developed for all experts within and outside our community. Feel free to explore the HARMONY Data Exploration Tools if you are seeking answers to your research questions or wish to gain insights from the data on the HARMONY Big Data Platform. Set the parameters according to your needs and observe the results in easy-to-understand graphs.
What can you do with it?
Introducing the HARMONY Outcome Prediction Calculator - is is a machine-learning model that provides individualized prediction of outcomes for AML patients aged 18-70 years that were not consolidated with allogeneic transplantation. The aim is to provide data-driven predictions to help clinicians decide if a patient should be considered for allogeneic transplantation, especially in countries where targeted therapies are not available. This tool is intended only for research purposes, as the algorithm has not been prospectively validated for clinical use.
What can you do with it?
Should you wish for more advanced data analytics and granular data, we will ask you to follow our Standard Operating Procedure to submit research questions. The HARMONY Platform provides robust analytic tools and algorithms to support your in-depth study.
For more information and to share your feedback on our data exploration tools -> please contact us >
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
